Your browser doesn't support javascript.
loading
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.
Cai, Tianyu; Gouble, Agnès; Black, Kathryn L; Skwarska, Anna; Naqvi, Ammar S; Taylor, Deanne; Zhao, Ming; Yuan, Qi; Sugita, Mayumi; Zhang, Qi; Galetto, Roman; Filipe, Stéphanie; Cavazos, Antonio; Han, Lina; Kuruvilla, Vinitha; Ma, Helen; Weng, Connie; Liu, Chang-Gong; Liu, Xiuping; Konoplev, Sergej; Gu, Jun; Tang, Guilin; Su, Xiaoping; Al-Atrash, Gheath; Ciurea, Stefan; Neelapu, Sattva S; Lane, Andrew A; Kantarjian, Hagop; Guzman, Monica L; Pemmaraju, Naveen; Smith, Julianne; Thomas-Tikhonenko, Andrei; Konopleva, Marina.
Afiliación
  • Cai T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Gouble A; Cellectis SA, Paris, France.
  • Black KL; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Skwarska A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Naqvi AS; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Taylor D; Department of Biomedical & Health Informatics, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Zhao M; School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yuan Q; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sugita M; Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Zhang Q; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Galetto R; Cellectis SA, Paris, France.
  • Filipe S; Cellectis SA, Paris, France.
  • Cavazos A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Han L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Kuruvilla V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Ma H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Weng C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Liu CG; Department of Experimental Therapeutics, The University of MD Anderson Cancer Center, Houston, TX, USA.
  • Liu X; Department of Experimental Therapeutics, The University of MD Anderson Cancer Center, Houston, TX, USA.
  • Konoplev S; Department of Hematopathology, The University of MD Anderson Cancer Center, Houston, TX, USA.
  • Gu J; School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tang G; Department of Hematopathology, The University of MD Anderson Cancer Center, Houston, TX, USA.
  • Su X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Al-Atrash G; Department of Stem Cell Transplantation and Cellular Therapy, The University of MD Anderson Cancer Center, Houston, TX, USA.
  • Ciurea S; Department of Stem Cell Transplantation and Cellular Therapy, The University of MD Anderson Cancer Center, Houston, TX, USA.
  • Neelapu SS; Department of Lymphoma and Myeloma, The University of MD Anderson Cancer Center, Houston, TX, USA.
  • Lane AA; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Guzman ML; Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Smith J; Cellectis SA, Paris, France.
  • Thomas-Tikhonenko A; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA. mkonople@mdanderson.org.
Nat Commun ; 13(1): 2228, 2022 04 28.
Article en En | MEDLINE | ID: mdl-35484100
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Trastornos Mieloproliferativos Límite: Animals / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Trastornos Mieloproliferativos Límite: Animals / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos